Migraine treatment guidelines and research updates

New clinical updates and research findings are reshaping the management of migraine. The American Academy of Neurology has updated its international treatment guidelines for the first time in 14 years. A key change involves lowering the threshold for starting preventive therapy; it is now recommended for patients experiencing four monthly migraine days, down from the previous threshold of eight days.

Modern treatments, specifically CGRP inhibitors, have established themselves as first-line options alongside traditional medications like topiramate, propranolol, and valproate. While effective, these newer drugs can be costly and may carry side effects.

Complementary research has also examined physical interventions. A systematic review and meta-analysis of 12 studies suggests that cervical strengthening and stabilization exercises may have the potential to reduce migraine-related impairments. However, the evidence remains limited, and it is currently unclear if these exercises provide a definitive preventive benefit.